DFM Platform

EniferBio Oy: Mycoprotein Innovation for European Strategic Autonomy

40 pages · PDF · 22 August 2025 · Licensed single-user copy, watermarked to the buyer

Tactical Biotechnology, Human Enhancement & MedTech Finland

Cover of the DFM report “EniferBio Oy: Mycoprotein Innovation for European Strategic Autonomy” — Defence-Finance Analysis, 40-page PDF

€499 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment

One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).

About this report

EniferBio Oy is a Finnish biotechnology venture transforming industrial waste into high-protein mycoprotein – an innovation with roots in 1970s Finland now poised to tackle 21st-century strategic challenges.

The company’s fermentation process, originally pioneered by the Finnish forest industry, produces a dried fungal protein powder comparable to soy or meat in nutritional value. By reviving and modernizing this legacy technology, EniferBio has emerged as a unique player in Europe’s quest for sustainable self-sufficiency.

Key questions this report answers

Who it's for

Investors screening EniferBio Oy, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.

Related reports

Methodology, format & delivery

DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (22 August 2025). You receive a 40-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.

Related on DFM

More Tactical reports · Biotechnology, Human Enhancement & MedTech · All reports

Prefer unlimited access?

Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →

Get the full report — €499 →